Viskase Holdings, Inc.
VISK · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Pettit Craig: Form 3
Insider disclosure · Filed · Report period 30 Apr 2026
-
Form 3
SEC filing · Filed
-
Form 10-K/A
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ENZN · 293904108 - Common Stock, par value $0.01 per share
Company details and SEC sources
CIK 0000727510 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- VISK on OTC
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 333 East Butterfield Road, Suite 400, Lombard, IL, 60148
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
-
ENZON PHARMACEUTICALS INC. (to 25 Mar 2026) ENZON PHARMACEUTICALS INC (to 23 Feb 2016) ENZON PHARMACEUTICALS INC (to 22 Mar 2006) ENZON PHARMACEUTICAL INC (to 10 Dec 2002) ENZON INC (to 09 Dec 2002)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields